Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
The use of enzyme inhibitors to clarify the role of thromboxane A2 in vasoocclusive disease has been complicated by their non-specific action. To address this problem we have examined the effects of thromboxane A2/prostaglandin endoperoxide receptor antagonism in a canine model of platelet-dependent...
Shranjeno v:
| izdano v: | J Clin Invest |
|---|---|
| Principais autores: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Clinical Investigation
1986
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC423371/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3003161/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI112329 |
| Oznake: |
Brez oznak, prvi označite!
|